CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Apr 8
Nasal swab testing of poultry workers and handlers in recent highly pathogenic H5N1 avian flu outbreak settings in Nigeria turned up seven positive results in humans, the European Centre for Disease Prevention and Control (ECDC) said in its weekly communicable disease threat report.
COVID-19 hospitalization and all-cause death rates for patients with end-stage kidney disease undergoing dialysis, as well as kidney transplant recipients, climbed steeply early in the pandemic, and both exhibited racial disparities, according to a study published yesterday in the Journal of the American Society of Nephrology (JASN).
"Young and healthy individuals, as well as other groups ... should have great respect for the virus."
With case counts and hospitalizations soaring, Michigan has emerged as the latest US hot spot.
Though Brazil has rightly received much attention, other South American nations are also reporting record activity.
COVID-related mobility restrictions such as stay-at-home orders had disproportionate burdens on women, minorities, and lower-income populations, according to a study yesterday in JAMA Network Open.
Antibiotics were initiated less frequently, and antivirals used more frequently, in patients diagnosed as having influenza using rapid polymerase chain reaction (RPCR) tests compared with standard multiplex PCR (MPCR) tests, Australian researchers reported yesterday in BMC Infectious Diseases.
The variant is behind the recent spike in cases, which has the US seeing 63,000 new cases a day on average.
Several countries have paused the vaccine while experts examine side effects.
Among 50 US cities studied, cases rose, on average, 59% in April 2020, a trend reflected in other nations.
In spite of an increase in days of supply, data still show discontinuation of some drugs.
Health First Europe (HFE) and the European Patient Group on Antimicrobial Resistance (AMR Patient Group) today launched their 2021 Declaration on AMR.
One in three COVID-19 survivors were diagnosed as having a neurologic or psychological condition within 6 months after their coronavirus diagnosis, according to a study yesterday in The Lancet Psychiatry. The researchers noted that disease severity was linked to higher risk.
Two studies describe new findings in MIS-C and the distinct but similar Kawasaki disease.
The ACP guidelines apply to inpatients and outpatients who have uncomplicated infections.
Also, experts continue to assess reports of rare blood clot conditions tied to the AstraZeneca vaccine.
"No more confusing rules, no more confusing restrictions. Everyone can get in line."
Nearly 40,000 US children 17 or younger may have lost a parent due to COVID-19 infection, according to a statistical model in JAMA Pediatrics today.
The results, published as a research letter, suggested that 1 in 13 COVID deaths result in a child losing a parent and that, as of February 2021, 37,300 children have been affected—more than 43,000 if using excess death data.
CARB-X announced today that it is awarding up to $3.6 million in funding to Novel Microdevices, Inc. of Baltimore to develop a rapid, portable molecular diagnostic test for sexually transmitted bacterial infections.
